Concurrent Investment Advisors LLC Has $824,000 Stock Holdings in HealthEquity, Inc. $HQY

Concurrent Investment Advisors LLC lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) by 288.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 8,996 shares of the company’s stock after buying an additional 6,678 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in HealthEquity were worth $824,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. True Wealth Design LLC raised its stake in HealthEquity by 3,522.2% in the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after purchasing an additional 317 shares in the last quarter. Farther Finance Advisors LLC raised its stake in HealthEquity by 59.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after purchasing an additional 146 shares in the last quarter. AlphaQuest LLC raised its stake in HealthEquity by 52.2% in the 3rd quarter. AlphaQuest LLC now owns 624 shares of the company’s stock worth $59,000 after purchasing an additional 214 shares in the last quarter. Larson Financial Group LLC raised its stake in HealthEquity by 24.4% in the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after purchasing an additional 123 shares in the last quarter. Finally, IFP Advisors Inc raised its stake in HealthEquity by 1,602.3% in the 3rd quarter. IFP Advisors Inc now owns 749 shares of the company’s stock worth $75,000 after purchasing an additional 705 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analysts Set New Price Targets

HQY has been the subject of several analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research note on Thursday, January 22nd. Royal Bank Of Canada dropped their price objective on shares of HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a research note on Wednesday, March 18th. KeyCorp lifted their price objective on shares of HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a research note on Thursday, January 8th. BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $85.00 to $105.00 in a research note on Thursday, April 9th. Finally, The Goldman Sachs Group cut shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price objective for the company. in a research note on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $111.79.

Check Out Our Latest Research Report on HQY

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $82.40 on Friday. The firm has a 50 day moving average of $80.91 and a 200-day moving average of $88.04. The stock has a market capitalization of $6.96 billion, a PE ratio of 33.50, a PEG ratio of 1.49 and a beta of 0.19. The company has a current ratio of 3.27, a quick ratio of 3.27 and a debt-to-equity ratio of 0.45. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $116.65.

HealthEquity (NASDAQ:HQYGet Free Report) last issued its earnings results on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.90 by $0.05. The company had revenue of $334.59 million during the quarter, compared to analysts’ expectations of $332.48 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The firm’s revenue was up 7.3% compared to the same quarter last year. On average, equities research analysts predict that HealthEquity, Inc. will post 3.84 EPS for the current fiscal year.

HealthEquity Profile

(Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Featured Articles

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.